Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

GlaxoSmithKline · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
immunogenicitysafetyvaccine
respiratory syncytial virus infections, respiratory syncytial virus (rsv), vaccine, safety, reactogenicity, immunogenicity, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811715
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.